Past and present grant successes for Melbourne Bioinformatics researchers (highlighted in bold).
Active
| Investigators | Project | Funding source | Amount (AUD) | Start | End |
|---|---|---|---|---|---|
| Peter Meikle (PI), Gemma Figtree, Andrew Lonie, Bernard Pope, Andrew Gilbert, Clare Bernard, Ashok Krishnamurthy, Dianna Magliano, Guy Krippner, Jean Yang, Anthony Keech, Steven Manos, Rhys Francis, Angela Webster, and Robert Grossman | Building an Australian cardiovascular disease data commons | Medical Research Future Fund | $2.9M | 2023 | 2027 |
| Christopher Hovens, Kate Drummond, Niall Corcoran, Bernard Pope and Stan Stylli | The Genetic Drivers of Brain Metastases | CASS Foundation | $65k | 2022 | 2023 |
| Anis Hamid, Ian Davis, Christopher Sweeney, Arun Azad, Ben Tran, Shahneen Sandhu, Chris Hovens, Niall Corcoran, Bernard Pope, Chol-hee Jung and Yi Sun | MEMENTO: Biomarker discovery in metastatic hormone sensitive prostate cancer | Below The Belt Research Fund, Australia and New Zealand Urogenital and Prostate Cancer Trials Group | $50k | 2021 | 2023 |
| Khalid Mahmood, Ingrid Winship, Daniel Buchanan, Peter Georgeson, Emma Barrance, Natalie Diepenhorst and Julie Toner | What can tumour mutational signatures tell us about the cause of familial colorectal cancer? | Cancer Council Victoria | $200k | 2021 | 2023 |
| Niall Corcoran, Paul Boutros, Robert Bristow, Margaret Centenera, Ian Collins, Rosalind Eeles, Vanessa Hayes, Chris Havens, Maarten ljzerman, Anthony Papenfuss, Belinda Parker, Daniel Park, Bernard Pope, Chris Sweeney and Ben Tran | PRECEPT – Prostate Cancer Prognosis and Treatment | Medical Research Future Fund and Movember Foundation | $5.3M | 2019 | 2023 |
| Andrew Lonie | Australian BioCommons | NCRIS via Bioplatforms Australia | $20M | 2019 | 2023 |
| Christopher Hovens, Niall Corcoran, Daniel Park and Anthony Costello | The genomic drivers of high risk prostate cancer | NHMRC | $595k | 2019 | 2022 |
| Bernard Pope | Translating genomics-driven bioinformatics into improved prevention and treatment of colorectal cancer | Victorian Health and Medical Research Fellowship, Department of Health and Human Services, Victoria | $800k | 2017 | 2022 |
Completed
| Investigators | Project | Funding source | Amount (AUD) | Start | End |
|---|---|---|---|---|---|
| Jeremy Goecks, Nuwan Goonasekera and Enis Afgan | Extending Galaxy for Large-scale and Integrative Biomedical Analyses | Chan Zuckerberg Initiative | $190k USD | 2021 | 2021 |
| Tim Stinear, Christopher Mcdevitt and Torsten Seemann | Essential gene regulation in multi-drug resistant Golden Staph: a new path towards control | NHMRC | $795k | 2018 | 2021 |
| Tim Stinear and Torsten Seemann | Understanding virulence of invasive Staphylococcus aureus | NHMRC | $784k | 2018 | 2020 |
| Bernard Pope | Using structural homology prediction to improve functional annotation of biologically important proteomes | Amazon AWS Cloud Credits for Research Program | $20k USD | 2017 | 2017 |
| Daniel Buchanan, Ingrid Winship, Amanda Spurdle, Aung Ko Win, Bernard Pope, Christophe Rosty and Finlay Macrae | Expanding diagnostic approaches for Lynch syndrome | NHMRC | $1.3M | 2017 | 2020 |
| Justin Zobel, Michael Parker, Andrew Ooi, Richard Sandberg, Andrew Lonie, Salvy Russo, Toby Allen, Irene Yarovsky, Tiffany Walsh, John Grundy, Maria Forsyth and Brian Smith | A high-performance cloud resource for computational modelling | ARC | $635k | 2017 | 2017 |
| Peter Cowan et al (including Matthew Wakefield) | Genetic modification to protect pig islets from T cell-mediated xenogeneic rejection | JRDF | $675k | 2017 | 2020 |
| Benjamin Howden, Martyn Kirk, Deborah Williamson, Torsten Seemann and Nigel French | A new genomic frontier for foodborne disease investigation | NHMRC | $751k | 2017 | 2019 |
| Kathryn North et al (including Andrew Lonie) | Preparing Australia for genomic medicine: a proposal by the Australian Genomics Health Alliance | MRFF | $25M | 2016 | 2021 |
| Martyn Kirk, Dieter Bulach and Kathryn Glass | Understanding the sources of Campylobacter in Australia | NHMRC | $558k | 2016 | 2019 |
| Dieter Bulach, David McCarthy, Darren Cottam, Michèle Gourmelon and Toby Prosser | Safe to swim with the bugs? From hazard identification to risk management | ARC | $435k | 2016 | 2020 |
| Tim Stinear, Benjamin Howden, Sacha Pidot and Torsten Seemann | New antibiotics from old microbes | NHMRC | $1.04M | 2016 | 2019 |
| Daniel Park and Daniel Buchanan | A functional assay to classify genetic variants in Lynch syndrome | NHMRC | $376k | 2016 | 2017 |
| Torsten Seemann, Benjamin Howden, Tim Stinear and Paul Johnson | Dissecting the molecular basis for emerging alcohol tolerance in VRE | NHMRC | $837k | 2015 | 2018 |
| John Heath, Melissa Southey, John Hopper, Andrew Lonie, Daniel Park, Tu Nguyen-Dumont, Gillian Dite and Bernard Pope | High risk genes for childhood cancer: using massively parallel sequencing to identify cancer susceptibility | Cancer Australia | $200k | 2014 | 2017 |
| Daniel Park, David Goldgar, Bernard Pope, Tu Nguyen-Dumont and Andrew Lonie | Mouse phenotype-driven breast cancer risk gene discovery | Cancer Council Victoria | $200k | 2014 | 2015 |
| Daniel Park, Leonie Quinn, Melissa Southey, Tim Stinear and Graham Taylor | Multi-sample DNA shearing system | Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne | $11k | 2014 | 2014 |
| Daniel Park and Bernard Pope | Massively parallel sequencing and PCR optimised for DNA-based diagnosis and discovery | NHMRC | $197k | 2012 | 2013 |